Semaglutide For MASH Among Five New Products Awaiting EMA Verdict

Sanofi’s MS Drug Tolebrutinib Due For Oral Explanation

 
• By Vibha Sharma
  
Think With Yes Or No Choice, Business Choices For Difficult Situations, Yes or no and question mark, man holding two wooden with yes or no word on it, making decision.
The EMA is deciding whether or not to recommend approving new products (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU CHMP

More from Product Reviews